Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
28648303
Public Release Type:
Journal
Publication Year: 2017
Affiliation: Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Electronic address: crebhol1@jhu.edu.; William B. Schwartz Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA.; Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY.; Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.; William B. Schwartz Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA.; Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, MN.; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.; Section of Preventive Medicine and Epidemiology, Department of Medicine, Boston University School of Medicine, Boston, MA; Section of Cardiology, Department of Medicine, Boston University School of Medicine, Boston, MA.; Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.; William B. Schwartz Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA.; Division of Nephrology, Department of Medicine, University of California, San Francisco School of Medicine, San Francisco, CA.; William B. Schwartz Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA.; Department of Epidemiology and Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
DOI:
https://doi.org/10.1053/j.ajkd.2017.04.025
Authors:
Rebholz Casey M, Inker Lesley A, Chen Yuan, Liang Menglu, Foster Meredith C, Eckfeldt John H, Kimmel Paul L, Vasan Ramachandran S, Feldman Harold I, Sarnak Mark J, Hsu Chi-Yuan, Levey Andrew S, Coresh Josef
Request IDs:
20522
Studies:
African American Study of Kidney Disease and Hypertension Study (Clinical Trial)
Using change in estimated glomerular filtration rate (eGFR) based on creatinine concentration as a surrogate outcome in clinical trials of chronic kidney disease has been proposed. Risk for end-stage renal disease (ESRD) and all-cause mortality associated with change in concentrations of other filtration markers has not been studied in chronic kidney disease populations.
